Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Beam Therapeutics (BEAM) Gross Profit: 2019-2024

Historic Gross Profit for Beam Therapeutics (BEAM) over the last 6 years, with Dec 2024 value amounting to $63.5 million.

  • Beam Therapeutics' Gross Profit fell 32.03% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.7 million, marking a year-over-year decrease of 84.07%. This contributed to the annual value of $63.5 million for FY2024, which is 83.18% down from last year.
  • Latest data reveals that Beam Therapeutics reported Gross Profit of $63.5 million as of FY2024, which was down 83.18% from $377.7 million recorded in FY2023.
  • In the past 5 years, Beam Therapeutics' Gross Profit registered a high of $377.7 million during FY2023, and its lowest value of $24,000 during FY2020.
  • Its 3-year average for Gross Profit is $167.4 million, with a median of $63.5 million in 2024.
  • Its Gross Profit has fluctuated over the past 5 years, first soared by 215,916.67% in 2021, then slumped by 83.18% in 2024.
  • Beam Therapeutics' Gross Profit (Yearly) stood at $24,000 in 2020, then surged by 215,916.67% to $51.8 million in 2021, then increased by 17.51% to $60.9 million in 2022, then skyrocketed by 520.01% to $377.7 million in 2023, then slumped by 83.18% to $63.5 million in 2024.